NM_015311.3:c.3937G>A

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_015311.3(OBSL1):​c.3937G>A​(p.Gly1313Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000067 in 1,552,208 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000098 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000064 ( 1 hom. )

Consequence

OBSL1
NM_015311.3 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7

Conservation

PhyloP100: 0.627
Variant links:
Genes affected
OBSL1 (HGNC:29092): (obscurin like cytoskeletal adaptor 1) Cytoskeletal adaptor proteins function in linking the internal cytoskeleton of cells to the cell membrane. This gene encodes a cytoskeletal adaptor protein, which is a member of the Unc-89/obscurin family. The protein contains multiple N- and C-terminal immunoglobulin (Ig)-like domains and a central fibronectin type 3 domain. Mutations in this gene cause 3M syndrome type 2. Alternatively spliced transcript variants encoding different isoforms have been found in this gene. [provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03221643).
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0000636 (89/1399862) while in subpopulation MID AF= 0.00228 (13/5706). AF 95% confidence interval is 0.00135. There are 1 homozygotes in gnomad4_exome. There are 46 alleles in male gnomad4_exome subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OBSL1NM_015311.3 linkc.3937G>A p.Gly1313Arg missense_variant Exon 12 of 21 ENST00000404537.6 NP_056126.1 O75147-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OBSL1ENST00000404537.6 linkc.3937G>A p.Gly1313Arg missense_variant Exon 12 of 21 1 NM_015311.3 ENSP00000385636.1 O75147-3

Frequencies

GnomAD3 genomes
AF:
0.0000985
AC:
15
AN:
152228
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000104
AC:
16
AN:
153440
Hom.:
0
AF XY:
0.000109
AC XY:
9
AN XY:
82504
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000200
Gnomad ASJ exome
AF:
0.000354
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000831
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000636
AC:
89
AN:
1399862
Hom.:
1
Cov.:
33
AF XY:
0.0000666
AC XY:
46
AN XY:
691000
show subpopulations
Gnomad4 AFR exome
AF:
0.0000631
Gnomad4 AMR exome
AF:
0.000277
Gnomad4 ASJ exome
AF:
0.000119
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000202
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000333
Gnomad4 OTH exome
AF:
0.000155
GnomAD4 genome
AF:
0.0000985
AC:
15
AN:
152346
Hom.:
0
Cov.:
34
AF XY:
0.000121
AC XY:
9
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.0000240
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000901
Hom.:
0
Bravo
AF:
0.0000718
ExAC
AF:
0.0000459
AC:
5
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Oct 17, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1313 of the OBSL1 protein (p.Gly1313Arg). This variant is present in population databases (rs766548555, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with OBSL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 289411). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Aug 10, 2016
Eurofins Ntd Llc (ga)
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 04, 2019
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

3M syndrome 2 Uncertain:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Uncertain:1
Jan 03, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: OBSL1 c.3937G>A (p.Gly1313Arg) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0001 in 153440 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in OBSL1 causing Three M Syndrome 2 (0.0001 vs 0.0011), allowing no conclusion about variant significance. c.3937G>A has been reported in the literature in individuals affected with neurodegeneration with ataxia however, authors concluded the causal variants were in SQSTM1 gene (Haack_2016). These report(s) do not provide unequivocal conclusions about association of the variant with Three M Syndrome 2. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 27545679). ClinVar contains an entry for this variant (Variation ID: 289411). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.014
T;.
Eigen
Uncertain
0.28
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.83
T;T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.032
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L;L
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
-0.60
N;.
REVEL
Benign
0.13
Sift
Benign
0.49
T;.
Sift4G
Benign
0.10
T;T
Polyphen
1.0
D;.
Vest4
0.51
MutPred
0.26
Loss of sheet (P = 0.1158);Loss of sheet (P = 0.1158);
MVP
0.25
MPC
0.74
ClinPred
0.17
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs766548555; hg19: chr2-220422194; API